Using novel screens to sort through libraries of drugs already approved for use in human patients, a team of Wisconsin researchers has identified several compounds that could be used to treat a rare and deadly neurological disorder.
“Don’t give up, my love, or I’ll give up with you, because I only live to see the fulfillment of this dream: that you may continue to live. Yours is a life sentence, not a death sentence.”
Waisman Center director Marsha M. Seltzer announced the appointments of two new associate directors: Len Abbeduto as Waisman Center Associate Director for the Behavioral Sciences and Albee Messing as Waisman Center Associate Director for the Biological Sciences.
Waisman Center scientist Albee Messing participated in a recent study that pinpointed the cause of certain types of muscular dystrophy that involve brain abnormalities. Messing’s lab created one of the critical strains of mice utilized …